Söderbergh A, Winqvist O, Norheim I, Rorsman F, Husebye E S, Dolva O, Karlsson F A, Kämpe O
Department of Internal Medicine, University Hospital, Uppsala University, Sweden.
Clin Endocrinol (Oxf). 1996 Oct;45(4):453-60. doi: 10.1046/j.1365-2265.1996.8040813.x.
Autoimmune destruction of the adrenal gland is the major cause of Idiopathic Addison's disease, but the significance of 21-hydroxylase autoantibodies and their correlation with the presence of other autoantibodies have not so far been investigated in a larger population of patients with Addison's disease. We have now characterized a cohort of patients with idiopathic Addison's disease (n = 97) regarding the specificity of autoantibodies against the adrenal cortex and, as Addison's disease can be either an isolated condition or part of a polyendocrine disorder, we investigated the presence of organ-specific polyendocrine autoimmunity in this patient population.
Cross-sectional study.
Autoantibodies were analysed with indirect immunofluorescence (IF) on tissue preparations, ELISA and in Western blots using bacterially expressed proteins.
Eighty-four per cent (81/97) of the patient sera recognized the steroid-producing cells of the adrenal cortex in indirect IF. The antigen was identified as 21-hydroxylase by 72% (70/97) of the patient sera in Western blots. Seven sera that were negative on adrenocortical IF identified 21-hydroxylase on Western blot, while eight IF-positive sera were 21-hydroxylase-negative. Five sera weakly recognized 17 alpha-hydroxylase in Western blots, but all of these were also positive for 21-hydroxylase. In 13 cases (12 women), the sera also reacted with testicular Leydig cells, and nine of these identified the side-chain cleavage (SCC) enzyme. Other clinically evident organ-specific autoimmune disorders were present in 40% of the 97 patients and abnormal titres of organ-specific antibodies were found in 60% of the patients.
In idiopathic Addison's disease, auto-antibodies against 21-hydroxylase are found in a majority of cases and this represents an important diagnostic tool. The enzyme 17 alpha-hydroxylase does not seem to constitute a major autoantigen in Addison's disease. In a subgroup of patients with autoantibodies to gonads, antibodies to SCC are produced, often in parallel with antibodies to 21-hydroxylase. In yet another subgroup the specificity of autoantibodies giving positive immunofluorescence is still unknown. Three patients revealed a polyendocrine syndrome which clinically resembles autoimmune polyendocrine syndrome (APS) type I, but serologically corresponds to APS type II. Polyendocrine disorders are often associated with Addison's disease, and screening, including quantification of autoantibodies, may help to identify those at risk of developing associated autoimmune disorders.
肾上腺的自身免疫性破坏是特发性艾迪生病的主要病因,但迄今为止,尚未在大量艾迪生病患者中研究21-羟化酶自身抗体的意义及其与其他自身抗体存在情况的相关性。我们现已对一组特发性艾迪生病患者(n = 97)的肾上腺皮质自身抗体特异性进行了特征分析,由于艾迪生病既可以是一种孤立病症,也可以是多内分泌腺疾病的一部分,因此我们调查了该患者群体中器官特异性多内分泌自身免疫的存在情况。
横断面研究。
使用组织制剂上的间接免疫荧光(IF)、酶联免疫吸附测定(ELISA)以及使用细菌表达蛋白的蛋白质印迹法分析自身抗体。
84%(81/97)的患者血清在间接免疫荧光中识别肾上腺皮质的类固醇生成细胞。在蛋白质印迹中,72%(70/97)的患者血清将该抗原鉴定为21-羟化酶。7份在肾上腺皮质免疫荧光检测中呈阴性的血清在蛋白质印迹中鉴定出21-羟化酶,而8份免疫荧光阳性血清为21-羟化酶阴性。5份血清在蛋白质印迹中微弱识别17α-羟化酶,但所有这些血清对21-羟化酶也呈阳性。在13例患者(12名女性)中,血清也与睾丸间质细胞发生反应,其中9例鉴定出侧链裂解(SCC)酶。97例患者中有40%存在其他临床上明显的器官特异性自身免疫性疾病,60%的患者发现器官特异性抗体滴度异常。
在特发性艾迪生病中,大多数病例中可发现针对21-羟化酶的自身抗体,这是一项重要的诊断工具。17α-羟化酶似乎不是艾迪生病中的主要自身抗原。在一组性腺自身抗体阳性的患者中,会产生SCC抗体,通常与21-羟化酶抗体同时出现。在另一亚组中,免疫荧光呈阳性的自身抗体的特异性仍然未知。3例患者表现出一种多内分泌腺综合征,临床上类似于自身免疫性多内分泌腺综合征(APS)I型,但血清学上符合APS II型。多内分泌腺疾病常与艾迪生病相关,包括自身抗体定量在内的筛查可能有助于识别有发生相关自身免疫性疾病风险的患者。